Thursday, August 6, 2026

Ubicare Targets 80%+ Operating Profit Growth in 2026 — Here’s What’s Changing in Its EMR and Platform Play

Ubicare reported a 46% increase in operating profit for 2025, driven by optimized revenue structures and plans for AI solutions in 2026.

PharmaResearch says AMWC appearance validates its standing as a global medical aesthetics company

PharmaResearch showcased its Rejuran aesthetic solutions at AMWC Korea 2026, winning an award and gaining global recognition in aesthetic medicine.

New Battery Tech Could Power Your Phone Longer—Even in 122°F Heat

A South Korean team has developed a nanoparticle electrolyte for lithium metal batteries, enhancing performance and lifespan significantly.

Tag: tumor therapy

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

Revolutionary In Situ Cancer Vaccines: Can They Cure Relapsed and Metastatic Cancer?

Inha University reveals a next-gen immunotherapy strategy using tumors from patients to treat relapsed and metastatic cancers.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.